Correspondence 0001104659-23-119045 from P3 Health Partners Inc. (PIII, PIIIW) (CIK 0001832511) (PIII)
P3 Health Partners Inc. (PIII, PIIIW) (CIK 0001832511)
Date: Nov. 16, 2023 · CIK: 0001832511 · Accession: 0001104659-23-119045
AI Filing Summary & Sentiment
File numbers found in text: 333-275457
Letter
November 16, 2023
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Nicholas O’Leary
Re: P3 Health Partners Inc. Registration Statement on Form S-3 Originally Filed November 9, 2023 Registration No. 333-275457
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on Monday, November 20, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as P3 Health Partners Inc. (the “Company”) or its counsel may request via telephone call to the staff. Please contact Elisabeth M. Martin of Latham & Watkins LLP at (617) 948-6018 to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Sincerely yours,
P3 Health Partners Inc.
Show Raw Text
CORRESP
1
filename1.htm
November 16, 2023
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Nicholas O’Leary
Re: P3
Health Partners Inc.
Registration Statement on Form S-3
Originally Filed November 9, 2023
Registration No. 333-275457
Ladies and Gentlemen:
In accordance with Rule 461
of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration
of the effective date of the above-referenced Registration Statement so that it will become effective on Monday, November 20, 2023,
at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as P3 Health Partners Inc. (the “Company”)
or its counsel may request via telephone call to the staff. Please contact Elisabeth M. Martin of Latham & Watkins LLP at (617)
948-6018 to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Sincerely yours,
P3 Health Partners Inc.
By:
/s/ Atul Kavthekar
Atul Kavthekar
Chief Financial Officer
cc: Jessica Puathasnanon, P3 Health
Partners Inc.
Wesley C. Holmes, Latham & Watkins LLP